0001209191-15-078373.txt : 20151104 0001209191-15-078373.hdr.sgml : 20151104 20151104155614 ACCESSION NUMBER: 0001209191-15-078373 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151102 FILED AS OF DATE: 20151104 DATE AS OF CHANGE: 20151104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INSITE VISION INC CENTRAL INDEX KEY: 0000802724 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943015807 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 965 ATLANTIC AVE STREET 2: -- CITY: ALAMEDA STATE: CA ZIP: 94501 BUSINESS PHONE: 5108658800 MAIL ADDRESS: STREET 1: 965 ATLANTIC AVE STREET 2: --- CITY: ALAMEDA STATE: CA ZIP: 94501 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEVY BRIAN CENTRAL INDEX KEY: 0001277458 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22332 FILM NUMBER: 151196823 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-11-02 1 0000802724 INSITE VISION INC INSV 0001277458 LEVY BRIAN 965 ATLANTIC AVE ALAMEDA CA 94501 1 0 0 0 Stock Option (right to buy) 0.56 2015-11-02 4 D 0 56250 D 2012-09-16 2021-09-16 Common Stock 56250 0 D Stock Option (right to buy) 0.44 2015-11-02 4 D 0 150000 D 2012-12-14 2021-12-14 Common Stock 150000 0 D Stock Option (right to buy) 0.32 2015-11-02 4 D 0 150000 0.35 D 2013-12-12 2022-12-12 Common Stock 150000 0 D Stock Option (right to buy) 0.23 2015-11-02 4 D 0 150000 0.35 D 2014-12-11 2023-12-11 Common Stock 150000 0 D Stock Option (right to buy) 0.22 2015-11-02 4 D 0 150000 0.35 D 2015-12-10 2024-12-10 Common Stock 150000 0 D In accordance with the terms of the Agreement and Plan of Merger, dated September 15, 2015, as amended and restated, by and among Thea Acquisition Corp ("Purchaser"), Ranbaxy, Inc. and InSite Vision Incorporated ("Issuer") pursuant to which Purchaser was merged with and into Issuer (the "Merger"), this stock option was cancelled at the effective time of the Merger without consideration because the exercise price of the stock option equaled or exceeded $0.35 per share. This option was cancelled in connection with the Merger in exchange for a cash payment per share equal to the difference between $0.35 and the exercise price of the option. /s/ Brian Levy 2015-11-04